British Journal of Medical & Surgical Urology
Volume 3, Issue 2 , Pages 59-64 , March 2010

The value of TNM tumour staging and serum alkaline phosphatase levels in predicting the presence of bone metastases in patients with renal cell carcinoma

  • M.J. George

      Affiliations

    • Department of Nuclear Medicine, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom
    • Department of Urology, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom
    • Corresponding Author InformationCorresponding author at: Department of Nuclear Medicine, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom. Tel.: +44 0 20 8203 4663/78 1382 0614; fax: +44 0 20 8518 3486.
  • ,
  • J. Buscombe

      Affiliations

    • Department of Nuclear Medicine, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom
  • ,
  • M. Al-Akraa

      Affiliations

    • Department of Urology, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom

Received 1 June 2009 ,Revised 22 December 2009 ,Accepted 4 January 2010.

References 

  1. Motzer RJ, Bander NH, Nanus DM. Renal cell carcinoma. N Engl J Med. 1996;335:865–875
  2. Blacher E, Johnson DE, Haynie TP. Value of routine radionuclide bone scans in renal cell carcinoma. Urology. 1985;26:432–434
  3. Rosen PR, Murphy KG. Bone Scintigraphy in the initial staging of patients with renal-cell carcinoma: concise communication. J Nucl Med. 1984;25:289–291
  4. Swanson DA, Orovan WL, Johnson DE, Giacco G. Osseous metastases secondary to renal cell carcinoma. Urology. 1981;18:556–561
  5. Althausen P, Althausen A, Jennings LC, Mankin HJ. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer. 1997;80:1103–1109
  6. Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PFA, Patard JJ, et al. Renal cell carcinoma guideline. Eur Urol. 2007;51:1502–1510
  7. Seaman E, Goluboff ET, Ross S, Sawczuk IS. Association of radionuclide bone scan and serum alkaline phosphatise in patients with metastatic renal cell carcinoma. Urology. 1996;48:692–695
  8. Koga S, Tsuda S, Nishikido M, Ogawa Y, Hayashi K, Hayashi T, et al. The diagnostic value of bone scan in patients with renal cell carcinoma. J Urol. 2001;166:2126–2128
  9. Shvarts O, Lam JS, Hyung KL, Han K, Figlin R, Belldegrun A. Eastern Cooperative Oncology Group Performance Status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol. 2004;172:867–870
  10. Kim H, Cho NH, Kim D, Kwon YM, Kim EK, Rha SH, et al. Renal cell carcinoma in South Korea: a multicenter study. Hum Pathol. 2004;35:1556–1563
  11. Jung K, Lein M, Ringsdorf M, Roigas J, Schnorr D, Loening SA, et al. Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma. J Urol. 2006;176:1326–1331
  12. Bos SD, Piers DA, Mensink HJA. Routine bone scan and serum alkaline phosphatase for staging in patients with renal cell carcinoma is not cost-effective. Eur J Cancer. 1995;31A:2422–2423
  13. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, et al. TNM staging of renal cell carcinoma, Workgroup No. 3 Union International Control Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:992–993
  14. Chevelle JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612–624
  15. Patard J, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23:2763–2771
  16. Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, Zanolla L, et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer. 2005;103:68–75

PII: S1875-9742(10)00002-9

doi: 10.1016/j.bjmsu.2010.01.001

British Journal of Medical & Surgical Urology
Volume 3, Issue 2 , Pages 59-64 , March 2010